Article Details

Alto Neuroscience, Inc. Announces Initiation of Phase 2 Study of Alto-203 in Patients with ...

Retrieved on: 2024-04-03 14:21:25

Tags for this article:

Click the tags to see associated articles and topics

Alto Neuroscience, Inc. Announces Initiation of Phase 2 Study of Alto-203 in Patients with .... View article details on hiswai:

Excerpt

Alto Neuroscience, Inc. announced the initiation of its Phase 2 double-blind, single- and multiple-dose study to determine the pharmacodynamic ...

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up